About Synairgen Synairgen is a clinical-stage respiratory drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. Synairgen is currently fully focused on progressing its inhaled interferon beta broad spectrum antiviral drug as an effective treatment for people suffering with COVID-19 infection. Synairgen s differentiating human biology BioBank platform and world-renowned international academic KOL network has broader applicability for lung viral defence in other respiratory disorders including asthma and COPD. Synairgen is quoted on AIM (LSE: SNG). For more information about Synairgen, please see www.synairgen.com SNG001 (inhaled Interferon beta) applicability to COVID-19
Advancement of Round Table for Sustainable Palm Oil Certification Process
Dekel Agri-Vision Plc, the West African focused agriculture company, is pleased to confirm that following significant advances made in 2020 preparing for the Round Table for Sustainable Palm Oil ( RSPO ) certification process, it has now engaged Proforest to undertake the final RSPO pre-audit of the Company s 100%-owned, vertically integrated palm oil project at Ayenouan. Proforest is an established independent organisation specialising in sustainable practices in the natural resources sector.
As part of the pre-audit, Proforest will undertake a review of Dekel s programmes and management systems and assess the processes and procedures put in place by the Company to manage environmental and social risks and impacts. The Proforest team will also look to identify opportunities for value addition through the adoption of environmental and social improvements and initiatives. This will allow any
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
挪騰股權再圖上市 陝西旅遊主營業務單一待改善 sina.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.tw Daily Mail and Mail on Sunday newspapers.
中來股份理財虧損發酵：或涉信披違規 董事長回應稱「起訴追討」 sina.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.tw Daily Mail and Mail on Sunday newspapers.